Literature DB >> 7841065

Inheritance and testicular cancer.

P W Nicholson1, S J Harland.   

Abstract

Statistical analysis of published data on the age of onset of germ cell tumours of the testis and of the prevalence of bilateral disease in familial and general cases suggest the following: 1. Patients with bilateral disease carry the same genetic predisposition as familial cases. 2. Males with the hereditary predisposition develop none, unilateral or bilateral tumours in the proportions 55%, 38% and 7% respectively. 3. One-third of all testis cancer patients are genetically predisposed to the disease. 4. The 2.2% risk to brothers of cases as reported elsewhere can be accounted for by the homozygous (recessive) inheritance of a single predisposing gene.

Entities:  

Mesh:

Year:  1995        PMID: 7841065      PMCID: PMC2033581          DOI: 10.1038/bjc.1995.86

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Bilateral primary germ cell tumors of testis.

Authors:  H J Hoekstra; T Wobbes; D T Sleyfer; H Schraffordt Koops
Journal:  Urology       Date:  1982-02       Impact factor: 2.649

2.  Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.

Authors:  H von der Maase; M Rørth; S Walbom-Jørgensen; B L Sørensen; I S Christophersen; T Hald; G K Jacobsen; J G Berthelsen; N E Skakkebaek
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

3.  Bilateral testicular germ cell tumors. Report of nine cases and review of the literature.

Authors:  K P Dieckmann; W Boeckmann; W Brosig; D Jonas; H W Bauer
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

4.  Bilateral testicular tumor.

Authors:  D W Bach; L Weissbach; J H Hartlapp
Journal:  J Urol       Date:  1983-05       Impact factor: 7.450

5.  A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice.

Authors:  T Noguchi; M Noguchi
Journal:  J Natl Cancer Inst       Date:  1985-08       Impact factor: 13.506

6.  Prevalence of contralateral testicular intraepithelial neoplasia (carcinoma in situ) in patients with testicular germ cell tumour. Results of the German multicentre study.

Authors:  V Loy; K P Dieckmann
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Familial testicular cancer and urogenital developmental anomalies.

Authors:  D J Tollerud; W A Blattner; M C Fraser; L M Brown; L Pottern; E Shapiro; A Kirkemo; T H Shawker; N Javadpour; K O'Connell
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

9.  Bilateral testicular germ cell malignancy.

Authors:  S M Ware; J Heyman; S Al-Askari; P Morales
Journal:  Urology       Date:  1982-04       Impact factor: 2.649

10.  [Testicular underlying pathology, especially mumps orchitis in patients developing testicular tumors (author's transl)].

Authors:  W Ehrengut; M Schwartau; R Hubmann
Journal:  Urologe A       Date:  1980       Impact factor: 0.639

View more
  15 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Increased predisposition to cancer in brothers and offspring of testicular tumor patients.

Authors:  Sarolta Gundy; Mária Babosa; Márta Baki; István Bodrogi
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

3.  Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence.

Authors:  R I Skotheim; S M Kraggerud; S D Fosså; A E Stenwig; T Gedde-Dahl ; H E Danielsen; K S Jakobsen; R A Lothe
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

Review 4.  Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.

Authors:  Mark H Greene; Christian P Kratz; Phuong L Mai; Christine Mueller; June A Peters; Gennady Bratslavsky; Alex Ling; Peter M Choyke; Ahalya Premkumar; Janet Bracci; Rissah J Watkins; Mary Lou McMaster; Larissa A Korde
Journal:  Endocr Relat Cancer       Date:  2010-03-08       Impact factor: 5.678

Review 5.  Molecular mechanisms of testicular carcinogenesis.

Authors:  D B Rukstalis
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 6.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

7.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

8.  Younger age-at-diagnosis for familial malignant testicular germ cell tumor.

Authors:  Phuong L Mai; Bingshu E Chen; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Istvan Bodrogi; Lajos Geczi; Edith Olah; Ketil Heimdal; Sophie D Fosså; Katherine L Nathanson; Larissa Korde; Douglas F Easton; Darshna Dudakia; Robert Huddart; Michael R Stratton; D Timothy Bishop; Elizabeth A Rapley; Mark H Greene
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

9.  Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives.

Authors:  L A Korde; A Premkumar; C Mueller; P Rosenberg; C Soho; G Bratslavsky; M H Greene
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

10.  The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred.

Authors:  Phuong L Mai; Michael Friedlander; Kathy Tucker; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Radka Lohynska; Gedske Daugaard; Stéphane Richard; Catherine Bonaïti-Pellié; Axel Heidenreich; Peter Albers; Istvan Bodrogi; Lajos Geczi; Edith Olah; Peter A Daly; Parry Guilford; Sophie D Fosså; Ketil Heimdal; Ludmila Liubchenko; Sergei A Tjulandin; Hans Stoll; Walter Weber; Douglas F Easton; Darshna Dudakia; Robert Huddart; Michael R Stratton; Lawrence Einhorn; Larissa Korde; Katherine L Nathanson; D Timothy Bishop; Elizabeth A Rapley; Mark H Greene
Journal:  Urol Oncol       Date:  2009-01-22       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.